权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

PATH Questionnaire Reliability and Validity Study

PATH 问卷信度和效度研究

基本信息

批准号：
9342787
负责人：
ROGER E TOURANGEAU
金额：
$ 79.26万
依托单位：
WESTAT, INC.
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-01 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9342787
关键词：
Adult Affect Age Alcohol or Other Drugs use Area Attitude Behavior Behavioral Biological Markers Cessation of life Characteristics Computer Assisted Computer software Congresses Contractor Data Data Collection Development Drug usage Education Equation Family Smoking Prevention and Tobacco Control Act Frequencies Future Generations Goals Health Health Surveys Household Interview Interviewer Investigation Investments Knowledge Length Light Longitudinal Studies Measurement Medical Memory Mental Health Methodology Methods Modeling Monitor National Institute of Drug Abuse Nature Outcome Parents Participant Patient Self-Report Pattern Perception Personality Persons Pharmacoepidemiology Policies Policy Maker Population Population Analysis Population Assessment of Tobacco and Health Procedures Psychometrics Questionnaires Reporting Research Research Personnel Research Priority Respondent Saliva Sampling Scientific Advances and Accomplishments Specialist Specimen Survey Methodology Surveys System Testing Time Tobacco Tobacco use Training United States United States Food and Drug Administration United States National Institutes of Health Validity and Reliability Work Youth authority base cigarette smoking design experience follow-up health data instrument national surveillance programs response saliva analysis statistics study population syntax tobacco control tobacco prevention tool trend young adult

项目摘要

PROJECT SUMMARY/ABSTRACT With a new generation of tobacco products either on the market or being developed, surveillance is critical to describe the changing patterns and correlates of tobacco use in the U.S. population. The Population Assessment of Tobacco and Health (PATH) Study is the first large research effort undertaken by the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). PATH is a national longitudinal study of tobacco use and health that is following approximately 46,000 U.S. household residents ages 12 and older. Westat is the research company leading the development, data collection, and analyses of PATH. Building on systems that are already in place at Westat, this proposal seeks to estimate the test-retest reliability and validity of the PATH questionnaires. A separate reliability and validity study of the PATH adult and youth round four instruments is proposed in which a national sample of 875 respondents will be interviewed in a subsample of the PATH sample areas. Respondents will be interviewed twice, with the re-interview completed within 10 to 17 days after the initial interview. For a subset of the items on which discrepancies are found, the questionnaire will include probes designed to shed light on the nature of the discrepancy. To assess the validity of answers to key items on tobacco use saliva specimens will be analyzed for biomarkers and, at the end of the reinterview, the interviewer will photograph the products used by the participant and they will be compared to the brands self-reported in the questionnaire. Additional methodological enhancements and analyses to broaden the scientific value of the study will be conducted to identify person-level variables associated with differing levels of reliability, identify characteristics of the questions that affect the reliability of the answers, and examine the convergence of different methods for estimating reliabilities. PATH will serve researchers, agencies, and policy makers with the most comprehensive and up-to-date data on the changing tobacco and substance use landscape of any survey to date. It is, thus, crucial to establish the reliability of the PATH data. The proposed team includes experienced survey methodology experts and tobacco control specialists. The project will advance knowledge of person-level predictors of reliable tobacco survey responses as well as characteristics of the survey items themselves that may produce more reliable and valid reporting; these findings will be incorporated in new tools to predict the reliability of survey questions, advancing measurement practices in the study of substance use behaviors.

项目摘要/摘要随着新一代烟草产品的上市或正在开发中，监测对于描述美国人口中烟草使用的变化模式和相关性。人口烟草与健康评估(PATH)研究是由国家烟草公司开展的第一项大型研究工作卫生研究院(NIH)和食品和药物管理局(FDA)。Path是一项全国性的纵向研究烟草使用和健康是跟随大约4.6万名12岁及以上的美国家庭居民的。 Westat是一家研究公司，负责PATH的开发、数据收集和分析。在基础上建设已在Westat部署的系统，该提案旨在评估重新测试的可靠性和 PATH问卷的效度。成人与青少年路径轮回的信度和效度研究本研究提出四个工具，以分样本方式对全国875名受访者进行访谈。路径采样区的。受访者将接受两次采访，重新采访将在10至在第一次面试后17天。对于发现差异的项的子集，调查问卷将包括旨在阐明差异性质的探头。要评估将对烟草使用唾液样本关键项目的答案的有效性进行生物标志物分析，并在复试结束后，面试官将拍摄参与者使用的产品，这些产品将与问卷中自我报告的品牌进行比较。其他方法改进和将进行分析以扩大研究的科学价值，以确定个人水平的变量与不同的可靠性级别相关联，确定影响可靠性的问题的特征答案，并检查不同估计可靠性的方法的收敛情况。路径将服务于研究人员、机构和政策制定者拥有有关变化的最全面和最新的数据到目前为止所有调查的烟草和物质使用情况。因此，至关重要的是要建立路径数据。拟议的小组包括经验丰富的调查方法专家和烟草控制专家。专家。该项目将促进对可靠烟草调查答复的人一级预测因素的了解。以及可能产生更可靠和有效报告的调查项目本身的特点；这些发现将被纳入新的工具，以预测调查问题的可靠性，物质使用行为研究中的测量实践。